Search Results

from
 
  

Patent
number
Title of the invention and abstract piece Date of publication of the patent
1 NZ302843A
A NUCLEIC ACID FROM A RRK GENE SUCH AS XA21 WHICH CONFERS RESISTANCE TO XANTHOMONAS IN A PLANT

The present invention provides a nucleic acid construct encoding polypeptides which confer resistance to Xanthomonas spp. The nucleic acid construct consists of a RRK polynucleotide sequence encoding a polypeptide comprising extracellular LRR (leucine rich repeats) domain and cytoplasmic protein kinase domain. The nucleic acids can be used to produce transgenic rice and tomato plants resistant t...

29.11.1999
2 NZ305855A
SUGAR MODIFIED CYTOSTATIC DERIVATIVES AND THEIR USE IN ANTITUMOUR COMPOSITIONS

This compound has the formula K-SP-L-AA1-AA2-C or an isomer or salt thereof wherein: K is an optionally regioselectively modified carbohydrate radical; Sp is an optionally substituted arylene or alkylene; L is -HN-C(S)- or 2-imino-1,3,5-triazine substituted in the 4th position by chloro or hydroxyalkylamino; AA1 and AA2 are independently an amino acid in the D or L configuration which can optional...

29.11.1999
3 NZ308842A
METHOD AND APPARATUS FOR COPY PROTECTION FOR VARIOUS RECORDING MEDIA USING A VIDEO FINGERPRINT

A method and apparatus for copyright protection for various recording media such as Digital Video Discs (DVDs) uses a combination of a Video Finger Print Signal and an Authenticating Signature to permit the player to handle either copy-protected or non-copy-protected media, in a manner that is difficult to compromise. Both a Video Finger Print Signal and an Authenticating Signature are recorded o...

29.11.1999
4 JP2983949B2
No name

A method and apparatus for requesting, receiving, processing, and providing information from a single source to a television viewer. An information provider is accessed via a communications link and specific data, which is separate and distinct from video signals received by the television receiver, is downloaded to the television receiver. The data provided by the information provider is database...

29.11.1999
5 JP2982695B2
No name

A redundancy check circuit is composed of the fuses corresponding to more significant column addresses and the fuses corresponding, for the ordinary write operation, to lesser significant column and also corresponding, for the block write operation, to the column mask signal. Thereby, during the block write operation, the lesser significant column addresses are invalidated and the redundancy signa...

29.11.1999
6 JP2982700B2
No name

A redundant decoder has a charge line, a plurality of fuse elements connected to the charge line and selectively broken for storing a first address assigned to a defective column group of memory cells and a plurality of switching transistors connected between the fuse elements and a ground line and gated with internal address signals representative of a second address assigned to a column group of...

29.11.1999
7 JP2982750B2
No name

A digital information processing system ensures illegal-copy protection of video and audio signals without changing the structure or format of a stream of multiplexed video, audio and data packets. A packet demultiplexer selects packets from a packet stream according to the packet identifiers (PID) of the packets. The packet demultiplexer has a first output port electrically connected to video and...

29.11.1999
8 JP2982971B2
No name

A method of producing a cavity package (31) around an assembled semiconductor device (24) is disclosed. The method includes providing a chip attach pad (25) having a plurality of chip attach pad straps (33), each strap extending outwardly from the outer edge of the chip attach pad and spaced about the edge of the bar pad; mounting integrated circuits (24) having bond pads on the chip attach pad; m...

29.11.1999
9 HU9801919A3
CARBOHYDRATE CONJUGATED BIO-ACTIVE COMPOUNDS

Methods and compositions are provided which increase the cellular uptake of bioactive materials by covalently bonding such compounds to carbohydrate moieties through chemical linkers using other than glycosidic bonds. Numerous carbohydrates, linkers and bioactive materials can be joined in this way to form novel compositions, which are collectively referred to herein as glinkosides. Preferred glin...

29.11.1999
10 HU9802336A3
A PROCESS FOR THE PREPARATION OF ANTHRACYCLINE ANTIBIOTICS

PCT No. PCT/EP96/01174 Sec. 371 Date Sep. 18, 1997 Sec. 102(e) Date Sep. 18, 1997 PCT Filed Mar. 19, 1996 PCT Pub. No. WO96/29335 PCT Pub. Date Sep. 26, 1996A process for the preparation of antibiotics of the anthracycline class of formula (A), wherein R1 is hydrogen, OH, or OCOR2, wherein R2 is a C1-C4-alkyl group; which comprises the epimerization of the 4' hydroxy group of the daunosamine resid...

29.11.1999
11 HU9900605A3
LIPOPOLYAMINES AS TRANSFECTION AGENTS, PREPARATION AND USE THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Lipopolyamines useful for the transfection of nucleic acid and methods of preparation thereof are disclosed. The lipopolyamines are of general formula I, in which R4 comprises at least one C10-C22 aliphatic radical.

29.11.1999
12 HU9900689A2
ERYTHROMYCIN A DERIVATIVES AND METHODS FOR THE PREPARATION THEREOF;ERITROMICIN A-SZÁRMAZÉKOK ÉS ELJÁRÁS AZOK ELŐÁLLÍTÁSÁRA

A találmány tárgya (I) általánős képletű, új eritrőmicin A származékők-, ahől R1 jelentése hidrőgénatőm vagy 1-6 szénatőmős alkilcsőpőrt; R2jelentése 1-6 szénatőmős alkilcsőpőrt vagy adőtt esetben szűbsztitűáltarilcsőpőrt; vagy R1 és R2 együtt egy 3-10 szénatőmős lineáris- vagyelágazó láncú alkilén gyűrűt, egy arilén-alkilén csőpőrtőt, ahől azalkiléncsőpőrt 2-3 szénatőmős; vagy ariléndialkiléncsőp...

29.11.1999
13 HU9900958A2
NEW DERIVATIVES OF 2-FLUORO-3-DE[(2,6-DIDEOXY-3-C-METHYL-3-0-METHYL-ALFA-L-RIBOHEXOPYRANOSYL)-OXY]-6-0-METHYL-3-OXO-ERYTROMYCIN, AND THEIR PREPARATION PROCESS;ÚJ 2-FLUOR-3-DE[(2,6-DIDEZOXI-3-C-METIL-3-O-METIL-ALFA-L-RIBOHEXOPIRANOZIL)OXI]-6-O-METIL-3-OXO-ERITROMICIN-SZÁRMAZÉKOK, ÉS ELŐÁLLÍTÁSUK

A találmány tárgyát az új, (I) általánős képletű vegyületek képezik -a képletben A jelentése hidrőxilcsőpőrt és B a 10-helyzetű szénatőmmalszén-szén kötést képez, vagy A és B együtt karbőnát- vagykarbamátcsőpőrtőt alkőt, és OZ jelentése szabad, észterezett vagyéterezettt hidrőxilcsőpőrt, valamint a fenti vegyületek savaddícióssói. A találmány tárgyát képezik tővábbá az (I) általánős képletűvegyüle...

29.11.1999
14 HU9901158A3
NOVEL METHOD FOR ISOMERISING THE 10-METHYL RADICAL OF ERYTHROMYCIN DERIVATIVES

PCT No. PCT/FR97/00840 Sec. 371 Date Nov. 11, 1998 Sec. 102(e) Date Nov. 11, 1998 PCT Filed May 13, 1997 PCT Pub. No. WO97/43297 PCT Pub. Date Nov. 20, 1997An isomerization method wherein a compound of formula wherein X and y together form a 3-oxo radical, or X is a hydrogen atom and Y is either a radical a where R2 is OH or O-acyl, or an O-alkyl or NH2 radical; R1 is a hydrogen atom or a methyl r...

29.11.1999
15 HU9902644A2
NOVEL ORTHOSOMYCINS FROM MICROMONOSPORA CARBONACEA;ÚJ ORTHOSOMYCINEK MICROMONOSPORA CARBONACEA-BÓL

A találmány tárgyát az új, a Micrőmőnőspőra carbőnacea var. Africananevű mikrőőrganizműs által termelt antibiőtikűmők és sóik, ezekelőállítása, az új vegyületeket tartalmazó gyógyszerkészítmények, ésbaktériűmős fertőzések kezelésére való alkalmazásűk képezik. Atalálmány szerinti vegyületek fermentálással, a fermentléből valószőkásős izőlálási műveletekkel és ezt követő krőmatőgráfiástisztítással á...

29.11.1999
16 DK791004T3
ACYLEREDE BENZYLGLYKOSIDER SOM INHIBITORER AF GLAT-MUSKELCELLER-PROLIFERATION

This invention relates to acylated benzylglycosides and a method for the use of acylated benzylglycosides as smooth muslce cell proliferation inhibitors and as therapeutic compositions for treating diseases and conditions which are characterized by excessive smooth muscle proliferation, such as restenosis. The acylated benzylglycosides of this invention are those of formula (I), where X is (a), (b...

29.11.1999
17 DK457250T3
BIFUNKTIONELLE KOBLINGSFORBINDELSER, KONJUGATER OG FREMGANGSMÅDER TIL FREMSTILLING DERAF

The present invention provides novel N-substituted hydrazine bifunctional compounds, novel N-substituted hydrazone derivatives of a cytotoxic reagent incorporating the bifunctional compounds, novel conjugates containing at least one cytotoxic reagent molecule reacted with the bifunctional compound and bound to a molecule reactive with a target cell population, methods for their production, and pha...

29.11.1999
18 AU3892699A
THREE-PHASE ROTARY SEPARATOR

The method of operating a rotating separator apparatus (32), to which fluid, including gas and liquids is supplied in a fluid jet via a nozzle, which includes separating the liquids from the gas, at a first zone within the rotating apparatus, and separating the liquids into liquids of differing density at a second zone within the apparatus. The separated liquids are removed via two open weirs (204...

29.11.1999
19 AU3901299A
HETERODUPLEX MUTATIONAL VECTORS AND USE THEREOF IN BACTERIA

The invention is based on the discovery that Duplex Mutational Vectors are active in prokaryotic cells that contain a strand transfer activity (RecA) and mismatch repair activity (MutS). Using this system a type of Duplex Mutational Vector, termed a Non-Chimeric Mutational Vector, having no RNA:DNA hybrid-duplex, was shown to be active in prokaryotic cells if protected from 3' exonuclease attack. ...

29.11.1999
20 AU3596399A
CYTOTOXIN-BASED BIOLOGICAL CONTAINMENT

Method of conditionally controlling the survivability of a recombinant cell population and of containing such cells to an environment or containing replicons to a host cell is based on the use of proteic killer systems including the E . coli relBE locus and similar systems found in Gram-negative and Gram-positive bacteria and Archae. Such system are generally based on a cytotoxin polypeptide an...

29.11.1999